Single dose delta‐9‐tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability
- 17 January 2016
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 81 (3) , 525-537
Abstract
Aim: We aimed to assess the analgesic efficacy, pharmacokinetics, tolerability and safety of a single dose of Δ9‐THC in patients with chronic abdominal pain resulting from chronic pancreatitis (CP).Methods: This was a randomized, single dose, double‐blinded, placebo‐controlled, two way crossover study in patients suffering from abdominal pain as result of CP (n = 24), post hoc subdivided into opioid and non‐opioid users. Δ9‐THC (8 mg) or active placebo (5 mg/10 mg diazepam) was administered orally in a double dummy design.Results: No treatment effect was shown for delta VAS pain scores after Δ9‐THC compared with diazepam. Δ9‐THC was well absorbed with a mean tmax of 123 min. No significant differences were found between Δ9‐THC vs. diazepam for alertness, mood, calmness or balance. Feeling anxious and heart rate were significantly increased after Δ9‐THC compared with diazepam. The most frequently reported adverse events (AEs) after Δ9‐THC administration were somnolence, dry mouth, dizziness and euphoric mood.Conclusions: A single dose of Δ9‐THC was not efficacious in reducing chronic pain resulting from CP, but was well tolerated with only mild or moderate AEs. The PK results in CP patients showed delayed absorption and an increased variability compared with healthy volunteers.Keywords
This publication has 60 references indexed in Scilit:
- Evaluation of Anti-Hyperalgesic and Analgesic Effects of Two Benzodiazepines in Human Experimental Pain: A Randomized Placebo-Controlled StudyPLOS ONE, 2013
- Corticostriatal functional connectivity predicts transition to chronic back painNature Neuroscience, 2012
- Guide to Receptors and Channels (GRAC), 5th editionBritish Journal of Pharmacology, 2011
- Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trialsBritish Journal of Clinical Pharmacology, 2011
- Pain and the brain: Specificity and plasticity of the brain in clinical chronic painPain, 2011
- Central sensitization: Implications for the diagnosis and treatment of painPain, 2011
- Opioid-Induced Hyperalgesia: Clinically Relevant or Extraneous Research Phenomenon?Current Pain and Headache Reports, 2011
- Randomized Placebo-Controlled Double-Blind Clinical Trial of Cannabis-Based Medicinal Product (Sativex) in Painful Diabetic NeuropathyDiabetes Care, 2009
- Reassessment of the role of cannabinoids in the management of painCurrent Opinion in Anaesthesiology, 2007
- Definitions and Classifications of PancreatitisPancreas, 1991